Nu Skin Enterprises Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Nu Skin Enterprises şirketinin kazançları yıllık ortalama -40.9% oranında azalırken, Personal Products sektörünün kazançları yıllık 3.8% oranında artan oldu. Gelirler yıllık ortalama 6.4% oranında azalan oldu.

Anahtar bilgiler

-40.9%

Kazanç büyüme oranı

-39.6%

EPS büyüme oranı

Personal Products Sektör Büyümesi	8.7%
Gelir büyüme oranı	-6.4%
Özkaynak getirisi	-14.6%
Net Marj	-5.8%
Son Kazanç Güncellemesi	30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Nu Skin Enterprises nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

DB:NUS Gelir, gider ve kazançlar (USD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Sep 24	1,775	-103	1,171
30 Jun 24	1,844	-148	1,206
31 Mar 24	1,905	-3	1,245
31 Dec 23	1,969	9	1,289
30 Sep 23	2,003	59	1,292
30 Jun 23	2,042	70	1,327
31 Mar 23	2,102	77	1,366
31 Dec 22	2,226	105	1,435
30 Sep 22	2,377	38	1,534
30 Jun 22	2,480	113	1,597
31 Mar 22	2,624	139	1,682
31 Dec 21	2,696	147	1,735
30 Sep 21	2,770	230	1,772
30 Jun 21	2,833	237	1,801
31 Mar 21	2,741	219	1,754
31 Dec 20	2,582	191	1,666
30 Sep 20	2,417	158	1,590
30 Jun 20	2,304	146	1,524
31 Mar 20	2,315	150	1,519
31 Dec 19	2,420	174	1,572
30 Sep 19	2,520	116	1,616
30 Jun 19	2,606	125	1,673
31 Mar 19	2,686	129	1,731
31 Dec 18	2,679	122	1,733
30 Sep 18	2,662	158	1,720
30 Jun 18	2,550	146	1,661
31 Mar 18	2,396	137	1,572
31 Dec 17	2,279	129	1,503
30 Sep 17	2,144	149	1,446
30 Jun 17	2,185	165	1,463
31 Mar 17	2,235	167	1,492
31 Dec 16	2,208	143	1,476
30 Sep 16	2,249	141	1,503
30 Jun 16	2,216	100	1,483
31 Mar 16	2,176	100	1,469
31 Dec 15	2,247	133	1,513
30 Sep 15	2,284	144	1,536
30 Jun 15	2,352	196	1,584
31 Mar 15	2,442	171	1,645
31 Dec 14	2,569	189	1,739
30 Sep 14	3,016	268	2,030
30 Jun 14	3,285	311	2,205
31 Mar 14	3,306	365	2,211
31 Dec 13	3,177	365	2,117

Kaliteli Kazançlar: NUS şu anda kârlı değil.

Büyüyen Kar Marjı: NUS şu anda kârlı değil.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: NUS kârlı değildir ve zararlar son 5 yılda yılda 40.9% oranında artmıştır.

Büyüme Hızlandırma: NUS 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: NUS kârlı olmadığından, geçmiş yıl kazanç büyümesinin Personal Products sektörüyle ( 10.8% ) karşılaştırılması zorlaşıyor.

Özkaynak Getirisi

Yüksek ROE: NUS hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -14.6% ) sahiptir.

Nu Skin Enterprises Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Third quarter 2024 earnings released: EPS: US$0.17 (vs US$0.74 loss in 3Q 2023)

Nu Skin Enterprises, Inc. to Report Q3, 2024 Results on Nov 07, 2024

Nu Skin Enterprises, Inc. to Report Q2, 2024 Results on Aug 08, 2024

First quarter 2024 earnings released: US$0.011 loss per share (vs US$0.23 profit in 1Q 2023)

Nu Skin Enterprises, Inc. to Report Q1, 2024 Results on May 08, 2024

Nu Skin Enterprises, Inc. to Report Q4, 2023 Results on Feb 14, 2024

Recent updates

Third quarter dividend of US$0.06 announced

Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on December 11, 2024

Third quarter 2024 earnings released: EPS: US$0.17 (vs US$0.74 loss in 3Q 2023)

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024 and Adjusts Earnings Guidance for the Year 2024

Nu Skin Introduces MYND360™, a New Line of Clinically Proven Supplements and Topicals for Mental Well-Being

Nu Skin Enterprises, Inc. to Report Q3, 2024 Results on Nov 07, 2024

Nu Skin Enterprises Appoints Mark A. Zorko to its Board of Directors and Audit Committee and Nominating and Corporate Governance Committee

Upcoming dividend of US$0.06 per share

New minor risk - Share price stability

New major risk - Revenue and earnings growth

Nu Skin Enterprises, Inc. Revises Financial Guidance for the Full Year of 2024

Nu Skin Enterprises, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Insufficient new directors

Upcoming dividend of US$0.06 per share

First quarter dividend of US$0.06 announced

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Second Quarter of 2024

First quarter 2024 earnings released: US$0.011 loss per share (vs US$0.23 profit in 1Q 2023)

Nu Skin Enterprises, Inc. Announces Quarterly Dividend, Payable on June 12, 2024

Now 21% undervalued after recent price drop

Nu Skin Enterprises, Inc., Annual General Meeting, Jun 05, 2024

Nu Skin Enterprises, Inc. to Report Q1, 2024 Results on May 08, 2024

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Now 22% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 22%

Fourth quarter dividend of US$0.06 announced

Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on March 6, 2024

Nu Skin Enterprises, Inc. to Report Q4, 2023 Results on Feb 14, 2024

Upcoming dividend of US$0.39 per share at 8.8% yield

Independent Director recently sold €254k worth of stock

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2023

Third quarter 2023 earnings released: US$0.74 loss per share (vs US$0.51 loss in 3Q 2022)

Nu Skin Enterprises, Inc. Announces Quarterly Dividend, Payable on December 6, 2023

Nu Skin Enterprises, Inc. to Report Q3, 2023 Results on Nov 01, 2023

New minor risk - Insider selling

Upcoming dividend of US$0.39 per share at 6.4% yield

Nu Skin Enterprises, Inc. Provides Earnings Outlook for the Third Quarter and Full-Year 2023

Nu Skin Enterprises, Inc. Announces Quarterly Dividend, Payable on September 6, 2023

Second quarter 2023 earnings released: EPS: US$0.54 (vs US$0.68 in 2Q 2022)

Nu Skin Enterprises, Inc. Appoints James D. Thomas as Chief Financial Officer

Nu Skin Enterprises, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Nu Skin Enterprises, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Nu Skin Enterprises, Inc.(NYSE:NUS) dropped from Russell 2000 Growth Index

Upcoming dividend of US$0.39 per share at 4.2% yield

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Second Quarter and Full Year Ended March 31, 2023

First quarter 2023 earnings released: EPS: US$0.23 (vs US$0.77 in 1Q 2022)

Nu Skin Enterprises Announces Quarterly Dividend, Payable on June 7, 2023

Chief Accounting Officer recently sold €110k worth of stock

Full year 2022 earnings released: EPS: US$2.10 (vs US$2.93 in FY 2021)

Nu Skin Enterprises, Inc. Announces Dividend Increase, Payable on March 8, 2023

Nu Skin Enterprises, Inc. to Report Q4, 2022 Results on Feb 15, 2023

Nu Skin Enterprises, Inc.(NYSE:NUS) dropped from S&P 400 Consumer Staples (Sector)

Nu Skin Enterprises Introduces the Next Generation of Smart Skincare with ageLOC LumiSpa iO

Upcoming dividend of US$0.39 per share

Third quarter 2022 earnings released: US$0.51 loss per share (vs US$0.99 profit in 3Q 2021)

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022

Nu Skin Enterprises, Inc. to Report Q3, 2022 Results on Nov 02, 2022

Chief Accounting Officer recently sold €63k worth of stock

Insider recently sold €254k worth of stock

Upcoming dividend of US$0.39 per share

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2022

Second quarter 2022 earnings released: EPS: US$0.68 (vs US$1.18 in 2Q 2021)

Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on September 7, 2022

Nu Skin Enterprises, Inc. Provides Revenue Guidance for the Second Quarter of 2022

Executive Chairman of the Board recently sold €955k worth of stock

Upcoming dividend of US$0.39 per share

First quarter 2022 earnings released: EPS: US$0.77 (vs US$0.94 in 1Q 2021)

Nu Skin Enterprises Announces Quarterly Dividend, Payable on June 8, 2022

Nu Skin Enterprises, Inc. to Report Q1, 2022 Results on May 04, 2022